Nephros NEPH
NASDAQ NEPH
$4.04 -0.37 (-8.29%)
As of: Aug 21, 2026 · 2:56 PM EDT

Nephros (NEPH) Operating Leases (2019 - 2026)

Nephros (NEPH) posted quarterly Operating Leases of $566000.0 for Q1 2026, down 41.59% year-over-year from $969000.0 in Q1 2025, and down 15.77% quarter-over-quarter from $672000.0 in Q4 2025.

Nephros (NEPH) Operating Leases (2019 - 2026) Analysis & Trends

Nephros' Operating Leases history runs 8 years deep, the most recent figure standing at $566000.0 for Q1 2026.

  • In Q1 2026, Operating Leases fell 41.59% year-over-year to $566000.0; the TTM figure through Mar 2026 stood at $566000.0 (down 41.59% YoY), while the FY2025 annual figure was $672000.0, down 36.78% from the prior year.
  • Operating Leases for Q1 2026 stood at $566000.0, down from $672000.0 in the prior quarter.
  • The five-year high for Operating Leases was $1.4 million in Q4 2023, with the low at $201000.0 in Q3 2022.
  • The 5-year median for Operating Leases is $705000.0 (2022), against an average of $777941.2.
  • The sharpest annual moves came in 2024 and 2026: Operating Leases surged 146.06% in 2024, then plunged 41.59% in 2026.
  • Nephros' Operating Leases stood at $705000.0 in 2022, then surged by 97.16% to $1.4 million in 2023, then slipped by 23.53% to $1.1 million in 2024, then plunged by 36.78% to $672000.0 in 2025, then retreated by 15.77% to $566000.0 in 2026.
  • Business Quant data shows NEPH's Operating Leases at $566000.0 in Q1 2026, $672000.0 in Q4 2025, and $774000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Intuitive Surgical 134.37 Bn 129.15 Bn 1.96 Bn
2 Becton Dickinson 52.52 Bn 51.66 Bn 2.32 Bn
3 Alcon 35.73 Bn 34.38 Bn 1.68 Bn
4 Resmed 33.65 Bn 32.18 Bn 861.22 Mn
5 Medline 29.14 Bn 26.47 Bn 2.22 Bn
6 West Pharmaceutical Services 25.08 Bn 24.64 Bn 329.20 Mn
7 Solventum 15.40 Bn 15.00 Bn 1.29 Bn
8 Cooper Companies 14.79 Bn 14.65 Bn 735.40 Mn
9 Baxter International 13.59 Bn 11.44 Bn 1.03 Bn
10 Nephros 43.86 Mn 39.16 Mn 4.03 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 458,000.00
Mar 31, 2026 566,000.00
Dec 31, 2025 672,000.00
Sep 30, 2025 774,000.00
Jun 30, 2025 872,000.00
Mar 31, 2025 969,000.00
Dec 31, 2024 1.06 Mn
Sep 30, 2024 1.15 Mn
Jun 30, 2024 1.22 Mn
Mar 31, 2024 1.31 Mn
Dec 31, 2023 1.39 Mn
Sep 30, 2023 469,000.00
Jun 30, 2023 534,000.00
Mar 31, 2023 618,000.00
Dec 31, 2022 705,000.00
Sep 30, 2022 201,000.00
Jun 30, 2022 358,000.00
Mar 31, 2022 351,000.00
Dec 31, 2021 340,000.00
Dec 31, 2020 759,000.00